51 JFK Parkway, Short Hills, NJ 07078
Monday, October 26, 2026

Insights & Analysis

Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.

All articles

Page 1 of 100 · 900 articles
Expired Prescriptions and Refills Beyond Authorization in PBM Audits
PBM Audits & Defense

Expired Prescriptions and Refills Beyond Authorization in PBM Audits

A PBM audit tests prescription validity and refill counts; the federal controlled-substance limit and the state general limit are…

Diana YastrovskayaOct 25, 2026
Practitioner Dispensing of Controlled Substances From the Office
DEA Investigations

Practitioner Dispensing of Controlled Substances From the Office

Dispensing controlled substances from the office triggers DEA records, labeling, and state permit duties that prescribing alone do…

Anthony MahajanOct 25, 2026
Pain Agreements and Urine Drug Screens: What DEA and Boards Expect
DEA Investigations

Pain Agreements and Urine Drug Screens: What DEA and Boards Expect

Treatment agreements, urine drug screens and PDMP checks build the record DEA and medical boards read to judge legitimate prescrib…

Anthony MahajanOct 25, 2026
FDA Inspection Classifications for Compounders: NAI, VAI and OAI
Compounding Pharmacy

FDA Inspection Classifications for Compounders: NAI, VAI and OAI

What FDA's NAI, VAI and OAI inspection classifications mean for a compounding pharmacy, and what an OAI finding can trigger next.

Diana YastrovskayaOct 25, 2026
DME Supplier Standards and Revocation for Noncompliance
Payor Disputes

DME Supplier Standards and Revocation for Noncompliance

DME suppliers can lose Medicare billing privileges for failed site visits, insurance lapses, or hours violations, not just claims…

Anthony MahajanOct 25, 2026
DME Standard Written Order Requirements
Payor Disputes

DME Standard Written Order Requirements

A missing element on a DME order under 42 CFR 410.38 denies the claim outright and can extrapolate into a large recoupment demand.

Anthony MahajanOct 25, 2026
Advice of Counsel as a Defense in Healthcare Fraud Prosecutions
Healthcare Fraud Defense

Advice of Counsel as a Defense in Healthcare Fraud Prosecutions

Advice of counsel can blunt a healthcare fraud case, but asserting it waives privilege and fails without full disclosure and good-…

Anthony MahajanOct 24, 2026
ERISA Preemption and State PBM Laws: What Pharmacies Can Enforce
PBM Audits & Defense

ERISA Preemption and State PBM Laws: What Pharmacies Can Enforce

Rutledge v. PCMA and PCMA v. Mulready mark where ERISA preempts state PBM audit and network laws, and where a pharmacy can still e…

Diana YastrovskayaOct 24, 2026
Disputing a Managed Care Plan Recoupment Notice
Payor Disputes

Disputing a Managed Care Plan Recoupment Notice

A Medicaid MCO recoupment notice starts a dispute under the plan's contract. State review, like New Jersey's PICPA process, follow…

Anthony MahajanOct 24, 2026